BACKGROUND AND OBJECTIVES: The impact of posttransplantation anemia on patient survival, renal allograft survival, and rate of acute rejection is not known. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 1023 patients who underwent kidney transplantation at one center from January 1992 through June 2003 were retrospectively analyzed. Posttransplantation anemia was defined as mean hemoglobin <11 g/dl after 3 mo after transplantation. Data on demographics, pretransplantation dialysis, previous transplant history, pretransplantation hemoglobin, degree of HLA mismatch, and donor characteristics were collected. Some of the posttransplantation data that were collected in addition to the hemoglobin included delayed graft function; diabetes; hypertension; induction and maintenance of immunosuppressive regimen; posttransplantation infections; and use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, statins, aspirin, and beta blockers. Cox regression models were used to assess the effects of posttransplantation anemia on each outcome: Mortality, graft survival, and rate of acute rejection. Median follow-up time was 4 yr. RESULTS: During the entire follow-up period, there were 89 (9%) deaths, 143 (14%) acute rejection episodes, and 235 (23%) kidney losses. In multivariate Cox regression models, being anemic after transplantation, after the first 90 d, was associated with increased overall mortality and increased renal allograft loss. Posttransplantation anemia was also associated with increased acute rejection rates. CONCLUSIONS: This study shows that posttransplantation anemia is associated with worse patient and graft survival and higher rates of acute rejection when compared with nonanemic renal transplant recipients.
BACKGROUND AND OBJECTIVES: The impact of posttransplantation anemia on patient survival, renal allograft survival, and rate of acute rejection is not known. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 1023 patients who underwent kidney transplantation at one center from January 1992 through June 2003 were retrospectively analyzed. Posttransplantation anemia was defined as mean hemoglobin <11 g/dl after 3 mo after transplantation. Data on demographics, pretransplantation dialysis, previous transplant history, pretransplantation hemoglobin, degree of HLA mismatch, and donor characteristics were collected. Some of the posttransplantation data that were collected in addition to the hemoglobin included delayed graft function; diabetes; hypertension; induction and maintenance of immunosuppressive regimen; posttransplantation infections; and use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, statins, aspirin, and beta blockers. Cox regression models were used to assess the effects of posttransplantation anemia on each outcome: Mortality, graft survival, and rate of acute rejection. Median follow-up time was 4 yr. RESULTS: During the entire follow-up period, there were 89 (9%) deaths, 143 (14%) acute rejection episodes, and 235 (23%) kidney losses. In multivariate Cox regression models, being anemic after transplantation, after the first 90 d, was associated with increased overall mortality and increased renal allograft loss. Posttransplantation anemia was also associated with increased acute rejection rates. CONCLUSIONS: This study shows that posttransplantation anemia is associated with worse patient and graft survival and higher rates of acute rejection when compared with nonanemic renal transplant recipients.
Authors: Claudio Rigatto; Patrick Parfrey; Robert Foley; Carol Negrijn; Carrie Tribula; John Jeffery Journal: J Am Soc Nephrol Date: 2002-04 Impact factor: 10.121
Authors: Peter D Yorgin; John D Scandling; Amir Belson; Jaime Sanchez; Steven R Alexander; Kenneth A Andreoni Journal: Am J Transplant Date: 2002-05 Impact factor: 8.086
Authors: Claudio Rigatto; Robert Foley; John Jeffery; Carol Negrijn; Carrie Tribula; Patrick Parfrey Journal: J Am Soc Nephrol Date: 2003-02 Impact factor: 10.121
Authors: Wolfgang C Winkelmayer; Reshma Kewalramani; Mark Rutstein; Steven Gabardi; Tania Vonvisger; Anil Chandraker Journal: J Am Soc Nephrol Date: 2004-05 Impact factor: 10.121
Authors: Francesco Locatelli; Ronald L Pisoni; Christian Combe; Juergen Bommer; Vittorio E Andreucci; Luis Piera; Roger Greenwood; Harold I Feldman; Friedrich K Port; Philip J Held Journal: Nephrol Dial Transplant Date: 2004-01 Impact factor: 5.992
Authors: Yves Vanrenterghem; Claudio Ponticelli; José Maria Morales; Daniel Abramowicz; Keshwar Baboolal; Björn Eklund; Volker Kliem; Christophe Legendre; Antonio Luis Morais Sarmento; Flavio Vincenti Journal: Am J Transplant Date: 2003-07 Impact factor: 8.086
Authors: Michele F Eisenga; Marco van Londen; David E Leaf; Ilja M Nolte; Gerjan Navis; Stephan J L Bakker; Martin H de Borst; Carlo A J M Gaillard Journal: J Am Soc Nephrol Date: 2017-08-03 Impact factor: 10.121
Authors: Gabriel Choukroun; Nassim Kamar; Bertrand Dussol; Isabelle Etienne; Elisabeth Cassuto-Viguier; Olivier Toupance; François Glowacki; Bruno Moulin; Yvon Lebranchu; Guy Touchard; Maïté Jaureguy; Nicolas Pallet; Yannick Le Meur; Lionel Rostaing; Frank Martinez Journal: J Am Soc Nephrol Date: 2011-12-22 Impact factor: 10.121
Authors: Miklos Z Molnar; Adam G Tabak; Ahsan Alam; Maria E Czira; Anna Rudas; Akos Ujszaszi; Gabriella Beko; Marta Novak; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Istvan Mucsi Journal: Clin J Am Soc Nephrol Date: 2011-10-06 Impact factor: 8.237
Authors: Cristiane Becher Rosa; Isabele Cardoso Vieira de Castro; João Alves Reis Júnior; Juliana Silveira Aragão; Artur Felipe Santos Barbosa; Landulfo Silveira; Antonio L B Pinheiro Journal: Lasers Med Sci Date: 2014-01-11 Impact factor: 3.161
Authors: Pamala A Jacobson; David Schladt; William S Oetting; Robert Leduc; Weihau Guan; Arthur J Matas; Vishal Lamba; Roslyn B Mannon; Bruce A Julian; Ajay Israni Journal: Transplantation Date: 2011-02-15 Impact factor: 4.939
Authors: Zhongli Huang; Turun Song; Lei Fu; Zhengsheng Rao; Dongyang Zeng; Yang Qiu; Xianding Wang; Libo Xie; Qiang Wei; Li Wang; Tao Lin Journal: Int Urol Nephrol Date: 2015-08-06 Impact factor: 2.370